Biopharmaceutical Finance Crisis Focus of June 9th Symposium Sponsored by Yankee Public Relations

Yankee Public Relations is pleased to announce our inaugural life sciences symposium, designed to provide small and mid-sized biotechs with strategies for success in the present financial crisis. Biotech executives at public and private companies will share their experience, lessons learned and strategies for attracting investors. End Quote

Newark, NJ (1888PressRelease) April 29, 2009 - In the wake of the lingering financial crisis surrounding the biopharmaceutical industry, regional life science leaders will participate in “Funding Biopharma: Strategies for Reaching Investors in a Financial Crisis,” a symposium sponsored by Yankee Public Relations of Alexandria Township. The symposium will begin at 8 a.m. Tuesday, June 9 at the Basking Ridge Country Club, 185 Madisonville Rd., Basking Ridge.

“Biopharmaceutical companies around the country have been crushed by the meltdown of the financial markets,” said Yankee Public Relations President Fred Feiner, moderator of the program. “Record numbers of companies have failed as available funding has been cut dramatically, jeopardizing research and technology that could impact thousands of lives. Now, more than ever, biotechs need to find ways to influence potential investors and the public. Yankee PR’s inaugural life sciences symposium will bring together some of the most prominent leaders in biopharma today to focus on this important issue.”

Panelists include: Annarie Lyles, Ph.D., Genmab, senior vice president/head of business development; Ellen McDonald, M.B.A., Regado Biosciences, senior vice president, business operations and chief business officer; Andrew Reaume, Ph.D., M.B.A., Melior Discovery, president, chief executive officer and co-founder; Jeffrey H. Nicholas, J.D., Fox Rothschild, partner/chair, technology, venture finance and securities practices; John Pennett, C.P.A, Amper, Politziner & Mattia, partner/director of life sciences practice; Emilio Ragosa, J.D., Morgan Lewis, partner in business finance focusing on securities, mergers and acquisitions; Gene Detroyer, Five Prime Advisors, director; Avjit Roy, Ph.D., Five Prime Advisors, director; and Mike Page, United Biosource Corporation, senior director of regulatory affairs.

In three separate panel discussions, biopharmaceutical industry leaders will provide small and mid-sized biotechs with strategies for success in the present financial crisis. Biotech executives at public and private companies will share their experience, lessons learned and strategies for attracting investors. Representatives of the investment community will provide insights on the current marketplace and keys to funding opportunities. Industry leaders will discuss communications and regulatory strategies designed to maximize profitability.

Registration cost for the symposium is $30. All attendees must register by Friday, June 9 as on-site registration will not be available. Please visit www.yankeepr.com for registration information or contact Feiner at 908-894-3930 or fred ( @ ) yankeepr dot com dot

Yankee Public Relations
Yankee Public Relations LLC is a full-service, boutique marketing communications firm based in Alexandria Township, N.J. with more than 45 years of combined experience leading proactive media relations and marketing communications initiatives in the healthcare, pharmaceutical and finance industries. For more information, please visit www.yankeepr.com.

###

Visit Yankee Public Relations Website

space